Report cover image

Global Diammonium Glycyrrhizinate Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 195 Pages
SKU # APRC20362255

Description

Summary

According to APO Research, The global Diammonium Glycyrrhizinate market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Diammonium Glycyrrhizinate is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Diammonium Glycyrrhizinate is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Diammonium Glycyrrhizinate is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Diammonium Glycyrrhizinate is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Diammonium Glycyrrhizinate include Chia Tai Tianqing Pharmaceutical Group Co. Ltd, Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd, Suzhou Erye Pharmaceutical Co. Ltd, Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd, Jiangsu Tiansheng Pharmaceutical Co. Ltd, Sinopharm Guorui Pharmaceutical Co. Ltd and ND Pharma & Biotech Co. Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Diammonium Glycyrrhizinate, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Diammonium Glycyrrhizinate, also provides the revenue of main regions and countries. Of the upcoming market potential for Diammonium Glycyrrhizinate, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Diammonium Glycyrrhizinate revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Diammonium Glycyrrhizinate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Diammonium Glycyrrhizinate revenue, projected growth trends, production technology, application and end-user industry.

Diammonium Glycyrrhizinate Segment by Company

Chia Tai Tianqing Pharmaceutical Group Co. Ltd
Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd
Suzhou Erye Pharmaceutical Co. Ltd
Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd
Jiangsu Tiansheng Pharmaceutical Co. Ltd
Sinopharm Guorui Pharmaceutical Co. Ltd
ND Pharma & Biotech Co. Ltd.
Diammonium Glycyrrhizinate Segment by Type

Injection
Capsule
Diammonium Glycyrrhizinate Segment by Application

Chronic Viral Hepatitis
Immune Regulation
Diammonium Glycyrrhizinate Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diammonium Glycyrrhizinate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Diammonium Glycyrrhizinate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diammonium Glycyrrhizinate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Diammonium Glycyrrhizinate in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Diammonium Glycyrrhizinate company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diammonium Glycyrrhizinate revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Table of Contents

195 Pages
1 Market Overview
1.1 Product Definition
1.2 Diammonium Glycyrrhizinate Market by Type
1.2.1 Global Diammonium Glycyrrhizinate Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Injection
1.2.3 Capsule
1.3 Diammonium Glycyrrhizinate Market by Application
1.3.1 Global Diammonium Glycyrrhizinate Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Chronic Viral Hepatitis
1.3.3 Immune Regulation
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Diammonium Glycyrrhizinate Market Dynamics
2.1 Diammonium Glycyrrhizinate Industry Trends
2.2 Diammonium Glycyrrhizinate Industry Drivers
2.3 Diammonium Glycyrrhizinate Industry Opportunities and Challenges
2.4 Diammonium Glycyrrhizinate Industry Restraints
3 Global Growth Perspective
3.1 Global Diammonium Glycyrrhizinate Market Perspective (2020-2031)
3.2 Global Diammonium Glycyrrhizinate Growth Trends by Region
3.2.1 Global Diammonium Glycyrrhizinate Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Diammonium Glycyrrhizinate Market Size by Region (2020-2025)
3.2.3 Global Diammonium Glycyrrhizinate Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Diammonium Glycyrrhizinate Revenue by Players
4.1.1 Global Diammonium Glycyrrhizinate Revenue by Players (2020-2025)
4.1.2 Global Diammonium Glycyrrhizinate Revenue Market Share by Players (2020-2025)
4.1.3 Global Diammonium Glycyrrhizinate Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Diammonium Glycyrrhizinate Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Diammonium Glycyrrhizinate Key Players Headquarters & Area Served
4.4 Global Diammonium Glycyrrhizinate Players, Product Type & Application
4.5 Global Diammonium Glycyrrhizinate Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Diammonium Glycyrrhizinate Market CR5 and HHI
4.6.3 2024 Diammonium Glycyrrhizinate Tier 1, Tier 2, and Tier 3
5 Diammonium Glycyrrhizinate Market Size by Type
5.1 Global Diammonium Glycyrrhizinate Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Diammonium Glycyrrhizinate Revenue by Type (2020-2031)
5.3 Global Diammonium Glycyrrhizinate Revenue Market Share by Type (2020-2031)
6 Diammonium Glycyrrhizinate Market Size by Application
6.1 Global Diammonium Glycyrrhizinate Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Diammonium Glycyrrhizinate Revenue by Application (2020-2031)
6.3 Global Diammonium Glycyrrhizinate Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 Chia Tai Tianqing Pharmaceutical Group Co. Ltd
7.1.1 Chia Tai Tianqing Pharmaceutical Group Co. Ltd Comapny Information
7.1.2 Chia Tai Tianqing Pharmaceutical Group Co. Ltd Business Overview
7.1.3 Chia Tai Tianqing Pharmaceutical Group Co. Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (2020-2025)
7.1.4 Chia Tai Tianqing Pharmaceutical Group Co. Ltd Diammonium Glycyrrhizinate Product Portfolio
7.1.5 Chia Tai Tianqing Pharmaceutical Group Co. Ltd Recent Developments
7.2 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd
7.2.1 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Comapny Information
7.2.2 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Business Overview
7.2.3 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (2020-2025)
7.2.4 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Product Portfolio
7.2.5 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Recent Developments
7.3 Suzhou Erye Pharmaceutical Co. Ltd
7.3.1 Suzhou Erye Pharmaceutical Co. Ltd Comapny Information
7.3.2 Suzhou Erye Pharmaceutical Co. Ltd Business Overview
7.3.3 Suzhou Erye Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (2020-2025)
7.3.4 Suzhou Erye Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Product Portfolio
7.3.5 Suzhou Erye Pharmaceutical Co. Ltd Recent Developments
7.4 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd
7.4.1 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Comapny Information
7.4.2 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Business Overview
7.4.3 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (2020-2025)
7.4.4 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Diammonium Glycyrrhizinate Product Portfolio
7.4.5 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Recent Developments
7.5 Jiangsu Tiansheng Pharmaceutical Co. Ltd
7.5.1 Jiangsu Tiansheng Pharmaceutical Co. Ltd Comapny Information
7.5.2 Jiangsu Tiansheng Pharmaceutical Co. Ltd Business Overview
7.5.3 Jiangsu Tiansheng Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (2020-2025)
7.5.4 Jiangsu Tiansheng Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Product Portfolio
7.5.5 Jiangsu Tiansheng Pharmaceutical Co. Ltd Recent Developments
7.6 Sinopharm Guorui Pharmaceutical Co. Ltd
7.6.1 Sinopharm Guorui Pharmaceutical Co. Ltd Comapny Information
7.6.2 Sinopharm Guorui Pharmaceutical Co. Ltd Business Overview
7.6.3 Sinopharm Guorui Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (2020-2025)
7.6.4 Sinopharm Guorui Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Product Portfolio
7.6.5 Sinopharm Guorui Pharmaceutical Co. Ltd Recent Developments
7.7 ND Pharma & Biotech Co. Ltd.
7.7.1 ND Pharma & Biotech Co. Ltd. Comapny Information
7.7.2 ND Pharma & Biotech Co. Ltd. Business Overview
7.7.3 ND Pharma & Biotech Co. Ltd. Diammonium Glycyrrhizinate Revenue and Gross Margin (2020-2025)
7.7.4 ND Pharma & Biotech Co. Ltd. Diammonium Glycyrrhizinate Product Portfolio
7.7.5 ND Pharma & Biotech Co. Ltd. Recent Developments
8 North America
8.1 North America Diammonium Glycyrrhizinate Revenue (2020-2031)
8.2 North America Diammonium Glycyrrhizinate Revenue by Type (2020-2031)
8.2.1 North America Diammonium Glycyrrhizinate Revenue by Type (2020-2025)
8.2.2 North America Diammonium Glycyrrhizinate Revenue by Type (2026-2031)
8.3 North America Diammonium Glycyrrhizinate Revenue Share by Type (2020-2031)
8.4 North America Diammonium Glycyrrhizinate Revenue by Application (2020-2031)
8.4.1 North America Diammonium Glycyrrhizinate Revenue by Application (2020-2025)
8.4.2 North America Diammonium Glycyrrhizinate Revenue by Application (2026-2031)
8.5 North America Diammonium Glycyrrhizinate Revenue Share by Application (2020-2031)
8.6 North America Diammonium Glycyrrhizinate Revenue by Country
8.6.1 North America Diammonium Glycyrrhizinate Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Diammonium Glycyrrhizinate Revenue by Country (2020-2025)
8.6.3 North America Diammonium Glycyrrhizinate Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Diammonium Glycyrrhizinate Revenue (2020-2031)
9.2 Europe Diammonium Glycyrrhizinate Revenue by Type (2020-2031)
9.2.1 Europe Diammonium Glycyrrhizinate Revenue by Type (2020-2025)
9.2.2 Europe Diammonium Glycyrrhizinate Revenue by Type (2026-2031)
9.3 Europe Diammonium Glycyrrhizinate Revenue Share by Type (2020-2031)
9.4 Europe Diammonium Glycyrrhizinate Revenue by Application (2020-2031)
9.4.1 Europe Diammonium Glycyrrhizinate Revenue by Application (2020-2025)
9.4.2 Europe Diammonium Glycyrrhizinate Revenue by Application (2026-2031)
9.5 Europe Diammonium Glycyrrhizinate Revenue Share by Application (2020-2031)
9.6 Europe Diammonium Glycyrrhizinate Revenue by Country
9.6.1 Europe Diammonium Glycyrrhizinate Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Diammonium Glycyrrhizinate Revenue by Country (2020-2025)
9.6.3 Europe Diammonium Glycyrrhizinate Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Netherlands
9.6.9 Nordic Countries
10 China
10.1 China Diammonium Glycyrrhizinate Revenue (2020-2031)
10.2 China Diammonium Glycyrrhizinate Revenue by Type (2020-2031)
10.2.1 China Diammonium Glycyrrhizinate Revenue by Type (2020-2025)
10.2.2 China Diammonium Glycyrrhizinate Revenue by Type (2026-2031)
10.3 China Diammonium Glycyrrhizinate Revenue Share by Type (2020-2031)
10.4 China Diammonium Glycyrrhizinate Revenue by Application (2020-2031)
10.4.1 China Diammonium Glycyrrhizinate Revenue by Application (2020-2025)
10.4.2 China Diammonium Glycyrrhizinate Revenue by Application (2026-2031)
10.5 China Diammonium Glycyrrhizinate Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Diammonium Glycyrrhizinate Revenue (2020-2031)
11.2 Asia Diammonium Glycyrrhizinate Revenue by Type (2020-2031)
11.2.1 Asia Diammonium Glycyrrhizinate Revenue by Type (2020-2025)
11.2.2 Asia Diammonium Glycyrrhizinate Revenue by Type (2026-2031)
11.3 Asia Diammonium Glycyrrhizinate Revenue Share by Type (2020-2031)
11.4 Asia Diammonium Glycyrrhizinate Revenue by Application (2020-2031)
11.4.1 Asia Diammonium Glycyrrhizinate Revenue by Application (2020-2025)
11.4.2 Asia Diammonium Glycyrrhizinate Revenue by Application (2026-2031)
11.5 Asia Diammonium Glycyrrhizinate Revenue Share by Application (2020-2031)
11.6 Asia Diammonium Glycyrrhizinate Revenue by Country
11.6.1 Asia Diammonium Glycyrrhizinate Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Diammonium Glycyrrhizinate Revenue by Country (2020-2025)
11.6.3 Asia Diammonium Glycyrrhizinate Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Diammonium Glycyrrhizinate Revenue (2020-2031)
12.2 SAMEA Diammonium Glycyrrhizinate Revenue by Type (2020-2031)
12.2.1 SAMEA Diammonium Glycyrrhizinate Revenue by Type (2020-2025)
12.2.2 SAMEA Diammonium Glycyrrhizinate Revenue by Type (2026-2031)
12.3 SAMEA Diammonium Glycyrrhizinate Revenue Share by Type (2020-2031)
12.4 SAMEA Diammonium Glycyrrhizinate Revenue by Application (2020-2031)
12.4.1 SAMEA Diammonium Glycyrrhizinate Revenue by Application (2020-2025)
12.4.2 SAMEA Diammonium Glycyrrhizinate Revenue by Application (2026-2031)
12.5 SAMEA Diammonium Glycyrrhizinate Revenue Share by Application (2020-2031)
12.6 SAMEA Diammonium Glycyrrhizinate Revenue by Country
12.6.1 SAMEA Diammonium Glycyrrhizinate Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Diammonium Glycyrrhizinate Revenue by Country (2020-2025)
12.6.3 SAMEA Diammonium Glycyrrhizinate Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.